<DOC>
	<DOCNO>NCT01561092</DOCNO>
	<brief_summary>Growing international scientific evidence indicate positive effect SSRI treatment ( serotonin reuptake inhibitor ) stroke , beyond antidepressant effect . We wish conduct prospective randomise double blind placebo-controlled multicenter study combine neuroprotective antithrombotic effect SSRI treatment stroke . Deletion SERT ( serotonin transporter ) gene may influence treatment effect may risk factor stroke , aspect also wish explore . Hypotheses : 1 . SSRI treatment commence acute phase stroke ( day 2-5 ) protect new thromboembolic event lead good rehabilitation . 2 . A specific SERT genotype associate increase risk first ever stroke . 3 . A specific SERT genotype associate high risk post stroke depression . 600 stroke patient randomise either escitalopram placebo treatment 1:1 ratio genotyped accord SERT polymorphism . The treatment follow period 6 month . During 6 month 2 clinical follow visit , one telephone control one visit evaluate compliance regard medication . Patients MRI part routine investigation do upon admission ( approximately 300 patient ) control MRI 6 month . Additionally 400 patient , eligible participation randomise control trial , genotyped answer questionnaire 1 6 month .</brief_summary>
	<brief_title>Escitalopram Treatment In Acute Stroke</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>First ever ischemic stroke Age 18 year Exclusion Criteria Hemorrhagic stroke Dementia neurodegenerative disease Antidepressant treatment within 6 month admission Acute need antidepressant treatment Drug abuse condition may indicate noncompliant behavior Liver failure ( increase liver enzyme level 2 time upper limit ) Renal failure ( GFR 30 ) Hyponatremia ( Spotassium 130 mmol/l ) Actively bleed ulcer Fatal stroke severe co morbidity markedly decrease expect life span Prolonged QT interval ( QTc 500 m ) Ongoing treatment drug know prolong QT interval</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Stroke</keyword>
	<keyword>RCT</keyword>
	<keyword>SSRI</keyword>
	<keyword>Outcome</keyword>
</DOC>